Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

Todd Neale

November 25, 2024

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

News Opinion CV Team Dispatch

March 2020 News Roundup

L.A. McKeown

March 12, 2020

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Todd Neale

August 16, 2019

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

Presentation TVT 2016

What Do I Do With a Patient With Cryptogenic Stroke?

Presenter: Creighton W. Don

June 18, 2016

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

April 2025 Dispatch for the CV Team

November 2024 Dispatch for the CV Team

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

December 2021 News Roundup

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

January 2021 News Roundup

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

March 2020 News Roundup

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

What Do I Do With a Patient With Cryptogenic Stroke?

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content